Single Dose Study of BMS-820836

Inclusion Criteria: * Body Mass Index (BMI) of 18 to 30 kg/m2, inclusive and weight ≥ 50 kg * Right-handed, non-ambidextrous subjects for Part 2 * Men and women, ages 18 to 55 years, inclusive Exclusion Criteria: * Women of child bearing potential (WOCBP) who are unwilling or unable to use an acceptable method to avoid pregnancy for the entire study period and for up to 8 weeks after the last dose of investigational product * WOCBP using a prohibited contraceptive method * Women who are pregnant or breastfeeding * Sexually active fertile men not using effective birth control if their partners are WOCBP * Any significant acute or chronic medical illness * Current or recent (within 3 months) gastrointestinal disease * History of cholecystectomy * Any major surgery within 4 weeks of study drug administration * Any gastrointestinal surgery that could impact the absorption of study drug * Donation of blood or plasma to a blood bank or in a clinical study (except a screening visit) within 4 weeks of study drug administration * Blood transfusion within 4 weeks of study drug administration * Inability to tolerate/swallow oral medication * Difficulty with venipuncture and/or poor venous access * Self-reported smokers * Recent (within 1 year) of psychostimulant use (cocaine, methylphenidate, amphetamines, ecstasy) * Confirmed resting supine systolic blood pressure \> 130 mmHg * Confirmed resting supine diastolic blood pressure \> 80 mmHg * Confirmed QT value ≥ 500 msec * Confirmed QTc (Bazett) value ≥ 450 msec * History of any significant drug allergy (such as anaphylaxis or hepatotoxicity) * History of peppermint allergies * History of brain conditions (e.g. history of stroke, head trauma, etc.) * History of or current psychiatric conditions * History of claustrophobia